Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in…
The federated network is powering faster, smarter drug development across 175+ million patients worldwide BOSTON, June 24, 2025 /PRNewswire/ --…
Collaboration accelerates TAG1's Pb-212 generator development and supports PharmaLogic's mission to scale radiopharmaceutical innovation. ST. LOUIS, June 24, 2025 /PRNewswire/…
OXFORD, England and CHICAGO, Ill., June 24, 2025 /PRNewswire/ -- Today, Brainomix, a pioneer in stroke artificial intelligence (AI) imaging…
MACAU, June 23, 2025 /PRNewswire/ -- Brain science technology company PanBrain Tech Co., Ltd. drew widespread attention at the BEYOND…
NEW YORK, June 20, 2025 /PRNewswire/ -- Players such as GE HealthCare, Siemens Healthineers, Philips, and Canon Medical are investing…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- Equity Insider News Commentary…
New studies confirm the clear benefit of early acute treatment, the consistent effectiveness of REN over years, and its clinical…
RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in…
- First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date - -…